{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:54:54Z","timestamp":1791449694431,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41366-026-02153-9","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:52:33Z","timestamp":1783187553000},"page":"2021-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel berberine derivative B12 exhibits superior anti-obesity effects via targeting brown and white adipocyte dynamics"],"prefix":"10.1038","volume":"50","author":[{"given":"Wenqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxiong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zufang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-yan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-4136","authenticated-orcid":false,"given":"Xiaoting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-5145","authenticated-orcid":false,"given":"Tianhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"2153_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.pop.2024.04.007","volume":"51","author":"T Fuller","year":"2024","unstructured":"Fuller T, Newberry Z, Nasir M, Tondt J. Obesity. Prim Care. 2024;51:511\u201322.","journal-title":"Prim Care"},{"key":"2153_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ajhp\/zxae273","volume":"82","author":"L Cross","year":"2025","unstructured":"Cross L. Management of obesity. Am J Health Syst Pharm. 2025;82:48\u201359.","journal-title":"Am J Health Syst Pharm"},{"key":"2153_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","volume":"387","author":"GA Bray","year":"2016","unstructured":"Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387:1947\u201356.","journal-title":"Lancet"},{"key":"2153_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10552-017-0869-z","volume":"28","author":"I Romieu","year":"2017","unstructured":"Romieu I, Dossus L, Barquera S, Blottiere HM, Franks PW, Gunter M, et al. Energy balance and obesity: what are the main drivers? Cancer Causes Control. 2017;28:247\u201358.","journal-title":"Cancer Causes Control"},{"key":"2153_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/ajcn\/nqac031","volume":"115","author":"KD Hall","year":"2022","unstructured":"Hall KD, Farooqi IS, Friedman JM, Klein S, Loos RJF, Mangelsdorf DJ, et al. The energy balance model of obesity: beyond calories in, calories out. Am J Clin Nutr. 2022;115:1243\u201354.","journal-title":"Am J Clin Nutr"},{"key":"2153_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241309168","volume":"15","author":"CM Peterseim","year":"2024","unstructured":"Peterseim CM, Jabbour K, Kamath Mulki A. Metabolic syndrome: an updated review on diagnosis and treatment for primary care clinicians. J Prim Care Community Health. 2024;15:21501319241309168.","journal-title":"J Prim Care Community Health"},{"key":"2153_CR7","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","volume":"7","author":"M Matsuda","year":"2013","unstructured":"Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7:e330\u201341.","journal-title":"Obes Res Clin Pract"},{"key":"2153_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.706978","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol. 2021;12:706978.","journal-title":"Front Endocrinol"},{"key":"2153_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"Collaboration NCDRF","year":"2024","unstructured":"Collaboration NCDRFWorldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403:1027\u201350.","journal-title":"Lancet"},{"key":"2153_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1030180","volume":"10","author":"P Congdon","year":"2022","unstructured":"Congdon P, Amugsi D. Editorial: The obesity epidemic: causes, context, prevention. Front Public Health. 2022;10:1030180.","journal-title":"Front Public Health"},{"key":"2153_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"Collaborators GBDRF","year":"2020","unstructured":"Collaborators GBDRFGlobal burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223\u201349.","journal-title":"Lancet"},{"key":"2153_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1517\/13543776.2013.746314","volume":"23","author":"IP Singh","year":"2013","unstructured":"Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009 - 2012). Expert Opin Ther Pat. 2013;23:215\u201331.","journal-title":"Expert Opin Ther Pat"},{"key":"2153_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/13543776.2021.1974001","volume":"32","author":"Y Kong","year":"2022","unstructured":"Kong Y, Li L, Zhao LG, Yu P, Li DD. A patent review of berberine and its derivatives with various pharmacological activities (2016-2020). Expert Opin Ther Pat. 2022;32:211\u201323.","journal-title":"Expert Opin Ther Pat"},{"key":"2153_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1083788","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu C, Li K, Peng XX, Yao TJ, Wang ZY, Hu P, et al. Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol. 2022;13:1083788.","journal-title":"Front Immunol"},{"key":"2153_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2147\/DMSO.S181572","volume":"11","author":"S Firouzi","year":"2018","unstructured":"Firouzi S, Malekahmadi M, Ghayour-Mobarhan M, Ferns G, Rahimi HR. Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action. Diabetes Metab Syndr Obes. 2018;11:699\u2013705.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2153_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/molecules27041351","volume":"27","author":"A Och","year":"2022","unstructured":"Och A, Och M, Nowak R, Podgorska D, Podgorski R. Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease. Molecules. 2022;27:4.","journal-title":"Molecules"},{"key":"2153_CR17","first-page":"3322","volume":"10","author":"X Hu","year":"2018","unstructured":"Hu X, Zhang Y, Xue Y, Zhang Z, Wang J. Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation. Am J Transl Res. 2018;10:3322\u20139.","journal-title":"Am J Transl Res"},{"key":"2153_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110137","volume":"127","author":"Z Ilyas","year":"2020","unstructured":"Ilyas Z, Perna S, Al-Thawadi S, Alalwan TA, Riva A, Petrangolini G, et al. The effect of Berberine on weight loss in order to prevent obesity: a systematic review. Biomed Pharmacother. 2020;127:110137.","journal-title":"Biomed Pharmacother"},{"key":"2153_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6493","volume":"5","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Zhang H, Li B, Meng X, Wang J, Zhang Y, et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun. 2014;5:5493.","journal-title":"Nat Commun"},{"key":"2153_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1706-y","volume":"10","author":"L Wu","year":"2019","unstructured":"Wu L, Xia M, Duan Y, Zhang L, Jiang H, Hu X, et al. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. Cell Death Dis. 2019;10:468.","journal-title":"Cell Death Dis"},{"key":"2153_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/cells8060632","volume":"8","author":"YC Lin","year":"2019","unstructured":"Lin YC, Lee YC, Lin YJ, Lin JC. Berberine promotes beige adipogenic signatures of 3T3-L1 cells by regulating post-transcriptional events. Cells. 2019;8:6.","journal-title":"Cells"},{"key":"2153_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.fitote.2009.10.010","volume":"81","author":"Y Hu","year":"2010","unstructured":"Hu Y, Davies GE. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia. 2010;81:358\u201366.","journal-title":"Fitoterapia"},{"key":"2153_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.phymed.2009.03.002","volume":"16","author":"Y Hu","year":"2009","unstructured":"Hu Y, Davies GE. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine. 2009;16:864\u201373.","journal-title":"Phytomedicine"},{"key":"2153_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50103-5","volume":"9","author":"C Wang","year":"2019","unstructured":"Wang C, Wang Y, Ma SR, Zuo ZY, Wu YB, Kong WJ, et al. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci Rep. 2019;9:13415.","journal-title":"Sci Rep"},{"key":"2153_CR25","doi-asserted-by":"publisher","first-page":"e0125667","DOI":"10.1371\/journal.pone.0125667","volume":"10","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tang H, Deng R, Wang N, Zhang Y, Wang Y, et al. Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity. PLoS ONE. 2015;10:e0125667.","journal-title":"PLoS ONE"},{"key":"2153_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms241411600","volume":"24","author":"JW Shou","year":"2023","unstructured":"Shou JW, Shaw PC. Berberine reduces lipid accumulation in obesity via mediating transcriptional function of PPARdelta. Int J Mol Sci. 2023;24:14.","journal-title":"Int J Mol Sci"},{"key":"2153_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3891806","volume":"2020","author":"HJ Park","year":"2020","unstructured":"Park HJ, Jung E, Shim I. Berberine for appetite suppressant and prevention of obesity. Biomed Res Int. 2020;2020:3891806.","journal-title":"Biomed Res Int"},{"key":"2153_CR28","doi-asserted-by":"publisher","first-page":"e24520","DOI":"10.1371\/journal.pone.0024520","volume":"6","author":"W Xie","year":"2011","unstructured":"Xie W, Gu D, Li J, Cui K, Zhang Y. Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL\/6J mice. PLoS One. 2011;6:e24520.","journal-title":"PLoS One"},{"key":"2153_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep14405","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep. 2015;5:14405.","journal-title":"Sci Rep"},{"key":"2153_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121141","volume":"311","author":"S Sun","year":"2022","unstructured":"Sun S, Yang Y, Xiong R, Ni Y, Ma X, Hou M, et al. Oral berberine ameliorates high-fat diet-induced obesity by activating TAS2Rs in tuft and endocrine cells in the gut. Life Sci. 2022;311:121141.","journal-title":"Life Sci"},{"key":"2153_CR31","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/onc.2017.296","volume":"36","author":"H Ruan","year":"2017","unstructured":"Ruan H, Zhan YY, Hou J, Xu B, Chen B, Tian Y, et al. Berberine binds RXRalpha to suppress beta-catenin signaling in colon cancer cells. Oncogene. 2017;36:6906\u201318.","journal-title":"Oncogene"},{"key":"2153_CR32","doi-asserted-by":"publisher","first-page":"15585","DOI":"10.1021\/jacs.0c07680","volume":"142","author":"X Jiang","year":"2020","unstructured":"Jiang X, Zeng Z, Hua Y, Xu B, Shen Y, Xiong J, et al. Merging C-H vinylation with switchable 6pi-electrocyclizations for divergent heterocycle synthesis. J Am Chem Soc. 2020;142:15585\u201394.","journal-title":"J Am Chem Soc"},{"key":"2153_CR33","doi-asserted-by":"crossref","unstructured":"Wang X, Zhao Y, Zhou D, Tian Y, Feng G, Lu Z. Gab2 deficiency suppresses high-fat diet-induced obesity by reducing adipose tissue inflammation and increasing brown adipose function in mice. Cell Death Dis. 2021;12:212.","DOI":"10.1038\/s41419-021-03519-9"},{"key":"2153_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cmet.2012.11.005","volume":"16","author":"M Derecka","year":"2012","unstructured":"Derecka M, Gornicka A, Koralov SergeiB, Szczepanek K, Morgan M, Raje V, et al. Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity. Cell Metab. 2012;16:814\u201324.","journal-title":"Cell Metab"},{"key":"2153_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185:419\u201346.","journal-title":"Cell"},{"key":"2153_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/jpps.2024.13157","volume":"27","author":"B Prapaharan","year":"2024","unstructured":"Prapaharan B, Lea M, Beaudry JL. Weighing in on the role of brown adipose tissue for treatment of obesity. J Pharm Pharm Sci. 2024;27:13157.","journal-title":"J Pharm Pharm Sci"},{"key":"2153_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ando.2024.05.006","volume":"85","author":"AC Carpentier","year":"2024","unstructured":"Carpentier AC, Blondin DP. Is stimulation of browning of human adipose tissue a relevant therapeutic target? Ann Endocrinol. 2024;85:184\u20139.","journal-title":"Ann Endocrinol"},{"key":"2153_CR38","doi-asserted-by":"crossref","unstructured":"van der Vaart JI, Boon MR, Houtkooper RH. The role of AMPK signaling in brown adipose tissue activation. Cells. 2021;10:1122.","DOI":"10.3390\/cells10051122"},{"key":"2153_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2153_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.molmed.2015.07.003","volume":"21","author":"AD van Dam","year":"2015","unstructured":"van Dam AD, Kooijman S, Schilperoort M, Rensen PC, Boon MR. Regulation of brown fat by AMP-activated protein kinase. Trends Mol Med. 2015;21:571\u20139.","journal-title":"Trends Mol Med"},{"key":"2153_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1 and the Mitochondria. Mol Cells. 2016;39:87\u201395.","journal-title":"Mol Cells"},{"key":"2153_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101097","volume":"42","author":"C Escalona-Garrido","year":"2020","unstructured":"Escalona-Garrido C, Vazquez P, Mera P, Zagmutt S, Garcia-Casarrubios E, Montero-Pedrazuela A, et al. Moderate SIRT1 overexpression protects against brown adipose tissue inflammation. Mol Metab. 2020;42:101097.","journal-title":"Mol Metab"},{"key":"2153_CR43","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.7150\/ijbs.62556","volume":"17","author":"Y Xu","year":"2021","unstructured":"Xu Y, Yu T, Ma G, Zheng L, Jiang X, Yang F, et al. Berberine modulates deacetylation of PPARgamma to promote adipose tissue remodeling and thermogenesis via AMPK\/SIRT1 pathway. Int J Biol Sci. 2021;17:3173\u201387.","journal-title":"Int J Biol Sci"},{"key":"2153_CR44","doi-asserted-by":"crossref","unstructured":"Moseti D, Regassa A, Kim WK. Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci. 2016;17:124.","DOI":"10.3390\/ijms17010124"},{"key":"2153_CR45","doi-asserted-by":"crossref","unstructured":"Lee JE, Schmidt H, Lai B, Ge K. Transcriptional and epigenomic regulation of adipogenesis. Mol Cell Biol. 2019;39:e00601-18.","DOI":"10.1128\/MCB.00601-18"},{"key":"2153_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117073","volume":"177","author":"HY Kim","year":"2024","unstructured":"Kim HY, Jang HJ, Muthamil S, Shin UC, Lyu JH, Kim SW, et al. Novel insights into regulators and functional modulators of adipogenesis. Biomed Pharmacother. 2024;177:117073.","journal-title":"Biomed Pharmacother"},{"key":"2153_CR47","doi-asserted-by":"crossref","unstructured":"Ambele MA, Dhanraj P, Giles R, Pepper MS. Adipogenesis: a complex interplay of multiple molecular determinants and pathways. Int J Mol Sci. 2020;21:4283.","DOI":"10.3390\/ijms21124283"},{"key":"2153_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","volume":"4","author":"ED Rosen","year":"1999","unstructured":"Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4:611\u20137.","journal-title":"Mol Cell"},{"key":"2153_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289\u2013312.","journal-title":"Annu Rev Biochem"},{"key":"2153_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","volume":"25","author":"MI Lefterova","year":"2014","unstructured":"Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293\u2013302.","journal-title":"Trends Endocrinol Metab"},{"key":"2153_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41421-022-00388-0","volume":"8","author":"Z Li","year":"2022","unstructured":"Li Z, Luo L, Yu W, Li P, Ou D, Liu J, et al. PPARgamma phase separates with RXRalpha at PPREs to regulate target gene expression. Cell Discov. 2022;8:37.","journal-title":"Cell Discov"},{"key":"2153_CR52","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1021\/acs.jmedchem.0c00088","volume":"63","author":"B Xu","year":"2020","unstructured":"Xu B, Jiang X, Xiong J, Lan J, Tian Y, Zhong L, et al. Structure-activity relationship study enables the discovery of a novel berberine analogue as the rxralpha activator to inhibit colon cancer. J Med Chem. 2020;63:5841\u201355.","journal-title":"J Med Chem"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02153-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:31:32Z","timestamp":1791448292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02153-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02153-9","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}